Animal studies show that GLP-1 drugs can reduce the urge to use alcohol, cocaine, and opioids, and even lower the risk of relapse
Bypassing the Weight Loss Narrative : Through secondary analyses, Northwestern scientists proved a vital mechanistic point: weight loss alone does not explain the increased risk of low blood pressure
OBrien R, OMalley D (2020) The glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of irritable bowel syndrome
Lombardini C, Helia RE, Boehlen F, Merlani P
Identified as the first incretin in the 1970s (see section I), GIP has historically been thought to have little therapeutic potential